Class IITerminatedD-0175-2023
Drug recall · February 1, 2023
Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator recall
Why: Short Fill
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator (racephedrine, USP 11.25), 30x0.5 mL Sterile Vials each in a foil pouch, NDC 0487-2784-01 UPC 3 04872 78401 4
- Lots / codes
Lot #: 126451 Exp. 04/30/2023
- Quantity
- 387,000 vials
- Company
- Nephron Sc Inc, West Columbia, SC
- Distribution
- Nationwide within the United States including Puerto Rico. Guatamala
- Initiated
- January 13, 2023 · Voluntary: Firm initiated
- Classified
- January 23, 2023
- Reported
- February 1, 2023
- Ended
- October 11, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Racepinephrine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.